About
Pragmaclin Research Inc. is using digital technology to help Parkinson's Disease patients with their flagship software, PRIMS. It empowers patients and clinicians to frequently access key information and improve the quality of care. Their mission is to be a global leader in supporting neurological disorders through digital technology, improving the quality of life for those living with these conditions. They were incorporated in March 2020 and have received funding from provincial and federal agencies. They have also won a pitch competition and are supported by notable sponsors and partners, including Professor K Ray Chaudhuri MD and Dr. Vinod Metta. Pragmaclin is based in St. John's, NF, and London, United Kingdom.